STAT6 and cancer: Given that various immunotherapies are being actively studied for treatment of advanced glioma [35], it may be possible that 5-Aza can sensitize GBM cancer cells to immunotherapy, and that STAT6, a critical mediator of chemokine induction, could be a key player in this sensitization mechanism.